The necessity of brain aromatization for sexual differentiation was investigated by treating pregnant guinea pigs with an aromatase inhibitor, 1,4,6-androstatriene-3,17-dione (ATD), from Day 30 to Day 55 of gestation. In postnatal Week 16, subjects were gonadectomized, and blood samples were collected after treatment with 10 Rg estradiol benzoate (EB), used to elicit an LH surge; subjects were subsequently treated with GnRH to test pituitary responsiveness. Plasma samples were assayed for LH by RIA. Prenatal ATD treatment did not affect the organization of the LH surge mechanism in either male or female subjects. All animals, regardless of sex or treatment, released LH after GnRH treatment, but the responsiveness of the gonadotroph to GnRH was attenuated in both males and females treated with ATD in utero. In addition, a significant sex difference in the pattern of LH released in response to a GnRH challenge was found. ATD-treated animals did not respond to the negative feedback actions of EB on LH secretion (p < 0.05), and the percentage of males displaying lordosis behavior was greater in this group than in controls (p < 0.05). Mounting behavior and lordosis behavior of females were not significantly affected by treatment. These data demonstrate a need for estrogen in the organization of brain areas that mediate negative feedback control of LH in both sexes and lordosis behavior in the male guinea pig. The organization of positive feedback mechanisms for controlling LH seems to be under androgenic control. Our data also suggest that the responsiveness of the gonadotroph to GnRH action is developmentally coordinated by prenatal estrogen and is sexually differentiated.
INTRODUCTION
The guinea pig is a long-gestation mammal in which sexual differentiation of the fetal brain takes place before birth [1] . From experiments in which offspring of pregnant guinea pigs were exposed to exogenous testosterone during a prenatal period critical for sexual differentiation, the idea arose that fetal androgens were responsible for sexual differentiation of the brain [1, 2] . This hypothesis was challenged by work in which female guinea pigs exposed to dihydrotestosterone, a nonaromatizable androgen, during the critical period for sexual development continued to show female behaviors in adulthood [3] . Subsequently it was shown that female guinea pigs exposed to synthetic estrogens in utero display masculine-typical behaviors as adults [4, 5] , and exposure to an aromatase inhibitor in utero prevented mounting behaviors in females but not in males [6] . Thus, it appears that in situ aromatization of androgen to estrogen during prenatal development is involved, at least in part, in the mechanism of sexual differentiation of the fetal guinea pig brain.
Aromatase activity has been found in fetal and neonatal brains of a number of vertebrate species [7] . Recently, we provided new information regarding its ontogeny and endocrine control in the fetal guinea pig. In these studies, aromatase activity did not differ as a function of fetal sex but was inducible by exogenous androgens in the septum, cortex, and medial basal hypothalamus [8] . To further understand the role of in situ estrogen formation in sexual differentiation of the guinea pig brain, we treated pregnant females with an aromatase inhibitor, 1,4,6-androstatriene-3,17-dione (ATD), during the critical period and assessed its effect on gonadotropin release and reproductive behaviors of adult animals.
MATERIALS AND METHODS

Animals
Female guinea pigs (500-750 g, Topeka strain) were housed for 8-10 days with sexually mature males, and the first day of vaginal opening was designated as Day 1 of gestation. Pregnant guinea pigs (n = 10) received s.c. injections of the aromatase inhibitor ATD (10 mg/kg BW, dissolved in sesame oil) or vehicle from Day 30 to Day 55 of gestation. The offspring from these treatments were weaned at 4 wk of age and housed according to sex and the following treatment groups: control females, n = 11; control males, n = 8; ATD females, n = 7; ATD males, n = 4. Of the control females, five were cannulated, but only three of these had an LH surge. Behavioral data were obtained from all eleven, however. We determined the dose of ATD to be used from a preliminary experiment as follows: we treated pregnant guinea pigs with various doses of ATD (0, 1.0, 2.5, 5.0, and 10.0 mg/kg BW) from Day 30 to Day 50 of gestation and assessed treatment effects on brain aromatase activity by a previously published and validated assay [9] . The results are presented in Table 1 . Brain aromatase activity of animals treated with the lowest dose of ATD (1.0 mg/kg BW) did not differ from control levels. Fetal brain aromatase activity of animals whose mothers received 2.5, 5.0, or 10.0 mg/kg BW ATD for 20 days was reduced 62.4, 55.6, and 71.0%, respectively, compared to the activity observed in oil-treated controls (Table 1) .
At 14 wk of age, the guinea pigs were placed on a reverse light cycle, compared to the usual colony schedule (i.e., lights-on at 2200 h and off at 1200 h). Two weeks later the animals were gonadectomized under anesthesia (ketamine [55 mg/ml] and xylazine [5.5 mg/ml], 0.5 ml/kg) and immediately received injections of prophylactic amounts of antibiotic (25 mg chloramphenicol sodium succinate, i.m.) on the day of and on the two days following surgery. The above protocol was used for all subsequent surgeries.
Catheterization and Serial Bleedings
One week after gonadectomy, we placed an indwelling catheter (i.d., 0.51 mm; o.d., 0.94 mm; Dow Corning, Midland, MI) into the jugular vein under ketamine-xylazine anesthesia. The catheter was threaded through the jugular vein; the distal end terminated in the right atrium. Silastic sheeting attached to the catheter was sutured to the brachiocephalic muscle to stabilize the preparation. The proximal end of the catheter was threaded under the skin to the back of the head and plugged with a gold pin. The patency of the catheter was maintained by use of 10 USP U/ ml heparin (Heparin Lock Flush; Abbott Laboratories, North Chicago, IL).
Tests of Positive Feedback Mechanisms and Pituitary Capacity
Blood (1.0 ml) was drawn at 1630 h on the day before an s.c. injection of estradiol benzoate (EB; 10 ,ug in 0.1 ml sesame oil) was administered at 0100 h, and blood samples were also drawn beginning 30 h after the EB injection for 18 h at 3-h intervals. After each collection, the blood was centrifuged to obtain plasma. The plasma was stored frozen at -20C for subsequent LH determinations. The pelleted cells were resuspended in 1 ml of 5% human plasma protein fraction (Protenate; Baxter Healthcare Corporation, Glendale, CA) containing 0.4 mg gentamicin sulfate and returned to the appropriate animal. The catheter was connected to an extension line, which allowed us to collect samples and return the resuspended cells without removing the animals from their cages during the entire blood collection procedure.
The effect of prenatal treatment with ATD on the capacity of subjects to release LH in response to a GnRH challenge was tested by treating each animal with a bolus of GnRH (1 ,ag/kg BW, i.v.) 56 h after the last blood sample was drawn, completing the EB challenge study. Blood samples (1.0 ml) were collected before and 15, 30, 60, 90, and 120 min after GnRH treatment. The samples were processed and the animals were treated as described above.
Hormone Assays
Plasma LH concentrations were determined by RIA with use of a monoclonal antibody to the -subunit of bovine LH (supplied by Dr. Janet Roser, University of California at Davis), NIADDK LHRP-2 as the reference preparation, and LER 1374A ovine LH for iodination. Serial dilutions of pituitary homogenates and sera from gonadectomized guinea pigs ran parallel to the standard curve as shown previously [10] . The sensitivity of this assay was 10 pg/tube, and the intra-and interassay coefficients of variation were 0.7 and 10.1%, respectively.
Behavior Tests
Sexual responsiveness of experimental animals was assessed by scoring the presence of the lordosis response elicited by the manual palpation technique [1] . The day after the GnRH challenge, the light cycle was changed back to normal (i.e., lights on at 0700 h and off at 2100 h). One week later, each animal received an injection of EB (10 ,ag, s.c.). Approximately 36 h later, a single injection of progesterone (500 Izg, s.c.) was administered, and the behavioral tests were begun. Each subject was manually stimulated in the genital-rump region, and the presence or absence of lordosis responses were recorded. This procedure was repeated once each hour for 8 h. One week after testing for female behaviors, two 3-cm silastic capsules containing testosterone propionate (i.d., 0.132 cm; o.d., 0.183 cm) were placed s.c. between the scapulae. After 2 wk of hormone treatment, male behaviors of the various groups were determined by testing subjects for mounting behaviors with estrogen/progesterone-primed spayed females as described above. The latency to first mount and the number of mounts performed by the test animal during a 10-min period were recorded. The test procedure was performed in the home cage of the animal to be tested.
Statistical Methods
LH concentrations were considered to be surge amounts if they were found to be greater than two standard deviations above the mean of the other post-EB values for the same animal. Plasma LH concentrations before and after EB treatment were analyzed by Student's t-test. Data obtained from GnRH-stimulated subjects and mounting behavior data were analyzed by the Mann-Whitney U-test. Lordosis behavior data were compared between groups by Chi-square analysis. 
Control female
Effects of Inhibiting Aromatization In Utero on Mechanisms that Control Gonadotropin Secretion
The effects of ATD treatment on feedback mechanisms that control LH release are presented in Figure 1 . Seventyseven percent of all females treated with EB released surge amounts of LH. Males, regardless of treatment, did not release LH in response to an estrogen challenge. Adult females exposed to ATD in utero did not differ from controls in their capacity to release surge amounts of LH in response to an estrogen challenge. Likewise, inhibition of brain aromatase activity in utero did not affect positive feedback mechanisms for LH release of adult males.
Plasma concentrations of LH in both control males and females declined significantly after treatment with estrogen (p < 0.05, negative feedback). Exogenous estrogen treatment, however, in both males and females was unable to significantly suppress LH concentrations in plasma of animals exposed to ATD in utero (p > 0.05, Fig. 1, C and D) . Six hours after the LH surge, baseline levels of LH were significantly higher in females exposed to ATD in utero than in controls (p < 0.05). Similarly, levels of LH after EB treatment were significantly higher in ATD-treated males then in controls (p < 0.05, Fig. 1, B and D) . These data indicate that even though ATD treatment in utero did not prevent estrogen from exerting positive feedback effects, the return of LH to baseline amounts differed between controls and ATD-treated subjects.
The responsiveness of the anterior pituitary gland of control and ATD-treated subjects to a bolus of GnRH is shown in Figure 2 . All animals in all groups released LH into the systemic circulation 15 min after GnRH treatment. However, in males and females the amount of LH found in the systemic circulation 15 min after a GnRH challenge was significantly lower in animals exposed to ATD in utero than in those exposed to the vehicle control (p < 0.05). The amount of LH released by treated females at 15 and 30 min after the GnRH challenge was significantly less than that released by control females (p < 0.05). LH levels were lower in sera of ATD-treated males at 15 min after the GnRH challenge than in sera of control males (p < 0.05).
In Figure 3 , the effect of treatment with ATD in utero on lordosis behavior of adult males and females is presented. A Chi-square analysis of the lordosis behavior indicated that significantly more males exposed to ATD in utero showed this behavior (p < 0.05) than did vehicle-treated controls. The lordosis behavior of the ATD-treated females, on the other hand, was not significantly different from that of controls (p > 0.05). Figure 4 shows data on indices of male behaviors, i.e., latency to first mount and number of mounts that occurred in a 10-min test period by the various treatment groups tested with receptive females and analyzed by a Mann-Whitney U-test. Based on the criterion of latency to first mount, control males and females differed significantly from one Effects of inhibiting brain aromatase activity in utero (treatment with ATD) on pituitary responsiveness to GnRH. Two days after last blood sample was drawn for experiment shown in Figure 1 , a bolus of GnRH (1 kg/kg BW) was administered through indwelling catheter. Blood samples were drawn through catheter at 15-min intervals for 2 h. The blood sample designated 0 was drawn immediately before administration of GnRH. Data are presented as means -SEM. Means marked with * differ significantly from Time 0 (p < 0.05), analyzed by Mann-Whitney U-test. Serum LH concentrations in ATD-treated animals were significantly lower than control levels at time points marked with * (p < 0.05). LH concentrations at 120 min after GnRH injection were significantly greater in males than in females of each treatment group (p < 0.05). Number of animals per treatment group: control female, n = 5; ATD female, n = 7; control male, n = 7; ATD male, n = 4.
another (p < 0.05). The significant sex difference in latency to first mount found in controls was retained between females exposed to ATD in utero and control males (p < 0.05), but not between treated males and control or treated females (p > 0.05). Based on the other criterion, the number of times that treatment animals mounted receptive females within our test paradigm, males displayed significandy higher levels of this behavior than females (p < 0.05). This aspect of mounting behavior of both males and females exposed to ATD in utero seems to have been affected in that the sex difference in this behavior usually found in untreated subjects was disrupted by the treatment.
DISCUSSION
We investigated the effects of inhibiting aromatase activity during the critical period for prenatal organization of
Effect of inhibiting brain aromatase activity in utero (treatment with ATD) on display of lordosis behavior of adult males and females. Bar marked * differs significantly from control (p < 0.05, Chi-square analysis). Number of animals per treatment group: control female, n = 11; ATD female, n = 7; control male, n = 7; ATD male, n = 5.
brain areas controlling gonadotropin release and reproductive behaviors in the guinea pig. The part of the guinea pig brain containing the LH surge mechanism is androgenized by endogenous hormones since males will not release LH in response to an estrogen challenge [11, 12] . Androgenization of the surge mechanism in females is readily achieved by prenatal treatment with testosterone [10] , but the capacity of males to release surge amounts of LH in response to an estrogen challenge was unaffected by exposing the fetus to either a S5a-reductase [11] or an aro- matase (present study) inhibitor during the critical period for sexual development. The reason for this failure is probably that testosterone per se can androgenize the central nervous system without being converted to an active metabolite. Alternatively, since metabolic functions in the fetal brain were not completely inhibited by exogenous inhibitors, it is not possible to rule out the importance of that which remains. Animals exposed to an aromatase inhibitor in utero were unable as adults, however, to respond to the negative feedback actions of estrogen on LH secretion. These data imply that the cellular events that mediate the organization of positive and negative feedback control mechanisms of gonadotropin release have different hormonal components or dose requirements for estrogen during fetal life. The present results differ from those of similar experiments using a 5oa-reductase inhibitor [11] . In those experiments, fetal guinea pigs of both sexes exposed to a 5ot-reductase inhibitor in utero were capable of responding to the negative feedback action of estrogen on LH secretion in adulthood [11] . Gonadectomized males thus treated, however, possess lower LH levels in their sera than do untreated controls, indicating that the development of mechanisms that control the postcastration rise of gonadotropin is androgen-dependent. Our experiments using an aromatase inhibitor support this conclusion since postcastration levels of LH were not affected by inhibition of aromatase activity prenatally.
In addition to the proposed requirement of estrogen in the development of the negative feedback machinery in the guinea pig, gonadotroph responsiveness in both males and females seems to be affected by inhibition of estrogen formation in utero. Since the anterior pituitary is devoid of aromatase activity in the rat [13] and guinea pig (unpublished data from our laboratory), inhibition of estrogens produced elsewhere in the placenta or in the fetus seems to be involved in this action on the pituitary gland. The amount of LH released by the anterior pituitary gland in response to a bolus of GnRH was attenuated in both males and females exposed to ATD during fetal development compared to control subjects. Although all animals in all treatment groups responded to GnRH treatment at 15 min by releasing LH into the systemic circulation, males differed from females in the pattern of LH release. Elevated concentrations of LH that persisted for 2 h were found in the systemic circulation of males in the last time period studied, but LH returned to baseline levels in the 2-h plasma samples obtained from female subjects. Although these results do not define the site of estrogen action, they seem to indicate that mechanisms of LH storage, synthesis, clearance, and/or status of the GnRH receptor on the gonadotroph, are influenced by prenatal estrogen action in this species. Since sex differences were found in the responsiveness of the gonadotroph to a GnRH challenge, these results seem to indicate that the anterior pituitary gland is also sexually differentiated. Even though Pfeiffer [14] originally concluded that the pituitary gland was sexually differentiated in the rat, an overwhelming body of evidence since then points to the central nervous system as the site where sexual differentiation takes place (reviewed in [15] ).
Reproductive behaviors of adult guinea pigs whose mothers received ATD during pregnancy have been reported previously [6] . Testosterone-induced mounting behavior was reduced by treatment in females but not in males [6] . Likewise, mounting behavior of male rats treated with ATD during the neonatal period was not affected by this treatment [16] . We did not find significant treatment effects on mounting behavior of males or females in the present study. But we did observe male/female differences in mounting behavior in control subjects that were not seen in experimental animals after ATD treatment. In contrast, the mounting behavior of male ferrets exposed to ATD prenatally was significantly lower than the same behavior in control males [17] .
The female behaviors of prenatal ATD-treated male ferrets were significantly elevated [18] . Prenatal [19, 20] and neonatal [16, 21] treatment of male rats with ATD prevented defeminization of their behavior. These observations on rats and ferrets were similar to our observations on male guinea pigs, the lordosis behavior of which was elevated by ATD treatment before birth. Others have shown that lordosis behavior of female guinea pigs was unaffected by exposure to the antiestrogen tamoxifen, in utero [4] , a finding similar to ours using ATD. However, reproductive behaviors of female guinea pigs exposed to synthetic estrogens during the critical period for sexual differentiation were masculinized and defeminized, and the sexual dimorphic nucleus was androgenized [4, 5] . Thus, it appears that aromatization of androgen in the brains of developing males constitutes an important link in the cellular events leading to sexual differentiation of the brain. Our data and those provided by others [4, 5] support the idea that feminization of reproductive behaviors is the consequence of a lack of local action of estradiol rather than some active hormonal process. Others believe, however, that low levels of estrogen mediate the organization of lordosis behavior in rats (evidence reviewed by Dohler [15] ). Likewise, female mice that develop in utero between two other females, and possess levels of estradiol-17{ in their amniotic fluid higher than levels in females that develop between two males, display higher levels of female sexual behaviors as adults [22, 23] . Finally, hypothalamic neurons obtained from mice do not develop neurite processes in vitro in the absence of estrogen [24, 25] .
In conclusion, we have shown that aromatization of androgen to estrogen is an important mediator of the cellular events leading to the development of mechanisms that control the negative feedback actions of estrogen on LH secretion and the capacity of gonadotrophs to respond to a GnRH challenge in guinea pigs. These conversions do not seem to be important for the development of the LH surge mechanism.
